COVID-19 therapies update: There are three potential pathways forming a bridge to a vaccine
Release Date:
You’ve probably heard the anti-malarial drug hydroxychloroqine is getting a hard look as a potential therapeutic agent in the fight against COVID-19. However, as Harvard Health Publishing senior faculty editor Dr. Rob Shmerling points out, evidence remains weak. On the brighter side, he points to three potential avenues in COVID-19 research where therapies may be put to use while a vaccine remains in development.
COVID-19 therapies update: There are three potential pathways forming a bridge to a vaccine